(Press-News.org) Bethesda, MD—University of North Carolina scientists have uncovered a new strategy that may one day help people with cystic fibrosis and chronic obstructive pulmonary disorder better clear the thick and sticky mucus that clogs their lungs and leads to life-threatening infections. In a new report appearing online in The FASEB Journal (http://www.fasebj.org), researchers show that the "SPLUNC1" protein and its derivative peptides may be able to help thin this thick mucus by affecting the epithelial sodium channel (ENaC). Not only does this research have implications for cystic fibrosis and COPD, but it also enhances the understanding of hypertension due to the role it also plays in controlling blood pressure.
"We hope that this study will pave the way for a new class of peptide-based channel inhibitors that can help reverse the mucus dehydration seen in Cystic Fibrosis and COPD," said Robert Tarran, Ph.D., a researcher involved in the work from the Cystic Fibrosis/Pulmonary Research and Treatment Center at the University of North Carolina in Chapel Hill. "This would help restore mucus clearance and kick-start the lung's ability to clear unwanted pathogens."
To identify which part of SPLUNC1 actually affects ENaC, scientists eliminated parts of the protein until it lost function. In fact, even after the eliminating 85 percent of SPLUNC1, it still affected ENaC, suggesting that the ENaC inhibitory domain was in the remaining 15 percent. Researchers then synthesized an 18-amino acid peptide of this region and tested its ability to bind to ENaC and to inhibit fluid absorption in human bronchial epithelial cells derived from people with and without cystic fibrosis. This peptide inhibited ENaC and fluid absorption in all systems tested, without affecting structurally-related ion channels. They also found that ENaC activity was affected for more than 24 hours in cystic fibrosis airway cultures, suggesting that this peptide may be therapeutically beneficial for the treatment of cystic fibrosis patients who suffer from over-active ENaC and consequentially have too little lung fluid.
"Breathing is something most healthy people take for granted." said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "However, people with cystic fibrosis and COPD battle for every breath because sticky mucus plugs their airways. This research should give scientists a new way of clearing the air for people with cystic fibrosis and COPD."
###Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal (http://www.fasebj.org) is published by the Federation of the American Societies for Experimental Biology (FASEB) and is among the most cited biology journals worldwide according to the Institute for Scientific Information. In 2010, the journal was recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century. FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Celebrating 100 Years of Advancing the Life Sciences in 2012, FASEB is rededicating its efforts to advance health and well-being by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Carey A. Hobbs, Maxime G. Blanchard, Stephan Kellenberger, Sompop Bencharit, Rui Cao, Mehmet Kesimer, William G. Walton, Matthew R. Redinbo, M. Jackson Stutts, and Robert Tarran. Identification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways. FASEB J, doi:10.1096/fj.12-207431 ; http://www.fasebj.org/content/early/2012/07/13/fj.12-207431.abstract
New proteins to clear the airways in cystic fibrosis and COPD
New research in the FASEB Journal suggests that SPLUNC1, an epithelial sodium channel inhibitor, and its synthetic derivatives may increase fluid levels and mucus clearance rates, allowing for better pathogen clearance in the lungs
2012-07-14
ELSE PRESS RELEASES FROM THIS DATE:
Questionnaire completed by parents may help identify 1-year-olds at risk for autism
2012-07-14
CHAPEL HILL, N.C. – A new study by University of North Carolina School of Medicine researchers found that 31 percent of children identified as at risk for autism spectrum disorders (ASD) at 12 months received a confirmed diagnosis of ASD by age 3 years.
In addition, 85 percent of the children found to be at risk for ASD based on results from the First Year Inventory (FYI), a 63-item questionnaire filled out by their parents, had some other developmental disability or concern by age three, said Grace Baranek, PhD, senior author of the study and an autism researcher with ...
Mechanical engineers develop an 'intelligent co-pilot' for cars
2012-07-14
CAMBRIDGE, MA -- Barrels and cones dot an open field in Saline, Mich., forming an obstacle course for a modified vehicle. A driver remotely steers the vehicle through the course from a nearby location as a researcher looks on. Occasionally, the researcher instructs the driver to keep the wheel straight — a trajectory that appears to put the vehicle on a collision course with a barrel. Despite the driver's actions, the vehicle steers itself around the obstacle, transitioning control back to the driver once the danger has passed.
The key to the maneuver is a new semiautonomous ...
Scaled-back NBAF and NBAF as designed are options that could meet critical US lab needs
2012-07-14
WASHINGTON — It is "imperative" that the U.S. build a large-animal biocontainment laboratory to protect animal and public health, says a new report by the National Research Council. Two options that could meet long-term needs include the National Bio- and Agro-Defense Facility (NBAF) facility as currently designed, or a scaled-back version tied to a distributed laboratory network. Until such a facility opens that is authorized to work with highly contagious foot-and-mouth disease, the Plum Island Animal Disease Center located off Long Island should remain in operation ...
Getting amped
2012-07-14
PASADENA, Calif.—Researchers at the California Institute of Technology (Caltech) and NASA's Jet Propulsion Laboratory (JPL) have developed a new type of amplifier for boosting electrical signals. The device can be used for everything from studying stars, galaxies, and black holes to exploring the quantum world and developing quantum computers.
"This amplifier will redefine what it is possible to measure," says Jonas Zmuidzinas, Caltech's Merle Kingsley Professor of Physics, the chief technologist at JPL, and a member of the research team.
An amplifier is a device that ...
Mutation in gene IDH a possible target for AML treatment
2012-07-14
Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week in the journal Leukemia & Lymphoma shows that this IDH mutation may be the first domino in a chain that leads to a more aggressive form of the disease.
"In fact, it's not IDH itself that causes the problem," says Dan Pollyea, MD, MS, investigator at the CU Cancer Center and assistant professor of hematologic oncology at the University of Colorado School of Medicine. Rather, the mutation in IDH leads to exponentially higher ...
Newer hip reconstruction technique provides good outcomes for athletes
2012-07-14
BALTIMORE, MD – A common, painful hip condition in elite athletes may be able to be repaired with an improved surgical technique, according to researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland today.
"In our review of 21 male, elite athletes who had a hip pain and instability issues (hypoplastic or labrum tear), 81 percent returned to play at a similar level as before they were hurt, after receiving an arthroscopic reconstruction technique using an ipsilateral iliotibial band autograft," ...
Platelet-rich plasma therapy a safe option for cartilage damage, new study finds
2012-07-14
BALTIMORE, MD – When it comes to treating cartilage tears in athletes, Platelet Rich Plasma (PRP) therapy is a safe and effective method of treatment, according to research presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in Baltimore.
"Using PRP therapy to repair cartilage is still relatively experimental, but studies like this show it's not only safe but also offers a significant improvement in function and quality of life for patients," said Elizaveta Kon, MD, lead author for the study and Director of Nano-Biotecnology ...
Study suggests changes in rotator cuff surgery rehabilitation needed
2012-07-14
A new Hospital for Special Surgery study suggests that the current rehabilitation used for patients undergoing tendon-bone repairs such as rotator cuff repair may be partially to blame for the high rates of failed healing after surgery. Experiments in a rat model of this injury suggest that immobilizing the limb for four to six weeks after surgery, rather than quickly starting physical therapy, improves healing.
"Before we did this study, we thought that delaying motion for a short period of time, seven to ten days, and then starting physical therapy would be the most ...
EzyTrainer Announces Free Accounts
2012-07-14
EzyTrainer.com, a unit of StivaSoft Ltd, announced today the FREE availability of its new online fitness booking software to personal trainers and fitness instructors wishing to automate client bookings and performance tracking. Fitness professionals can set up a remotely-hosted and managed account on EzyTrainer and then integrate the software into their own websites. This powerful software package helps fitness professionals manage their businesses in a number of important ways:
1. Coordinate Bookings: An online training schedule allows instructors to specify classes, ...
Sydney Artist Wins Cliftons Art Prize
2012-07-14
Sydney based artist, Vivian Falk, was awarded the Cliftons Art Prize for 2012 last week, from amongst more than 620 international artists located across Australia, New Zealand, Hong Kong and Singapore, for her painting of renowned racing icon Gai Waterhouse. The much talked about artwork entitled, 'Gai Waterhouse, 4am training', is now on permanent display in Cliftons award-winning Sydney Training & Conference venue.
Earlier this year, training and event facilities provider Cliftons invited emerging artists from across ten states to submit original artworks for ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] New proteins to clear the airways in cystic fibrosis and COPDNew research in the FASEB Journal suggests that SPLUNC1, an epithelial sodium channel inhibitor, and its synthetic derivatives may increase fluid levels and mucus clearance rates, allowing for better pathogen clearance in the lungs